Basilea Pharmaceutica AG Stock Xetra
Stocks
PK5
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
05:30:20 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 56.55 EUR | 0.00% |
|
0.00% | - |
| 08-05 | Swiss Market Index Extends Rally; Sandoz Shares Gain | MT |
| 08-05 | Basilea Pharmaceutica Bags Additional $5 Million Funding for Antibiotic Development | MT |
| Market Cap | 657M 809M 701M 599M 1.13B 77.17B 1.15B 7.74B 3.02B 38.63B 3.04B 2.97B 129B | P/E 2026 * |
14.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 507M 624M 541M 462M 870M 59.54B 884M 5.97B 2.33B 29.8B 2.34B 2.29B 99.42B | EV / Sales 2026 * |
1.93x | EV / Sales 2027 * | 1.65x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 2018-04-18 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 2019-04-09 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 2011-11-28 |
| Chairman | 71 | 2013-04-08 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 809M | |
| -1.52% | -1.40% | +2.28% | +14.16% | 49.24B | |
| -1.59% | +2.12% | +460.02% | +573.56% | 43.3B | |
| -0.85% | +7.95% | +15.77% | +80.09% | 40.48B | |
| -0.08% | +3.91% | +26.96% | +9.86% | 39.75B | |
| 0.00% | +3.59% | +20.51% | +48.00% | 32.67B | |
| -3.61% | -1.45% | - | - | 16.23B | |
| -2.52% | -0.52% | +24.35% | +118.05% | 16.24B | |
| +0.77% | +1.20% | +4.62% | +22.51% | 14.04B | |
| -1.09% | +5.94% | +81.46% | +31.15% | 13.43B | |
| Average | -1.05% | +2.30% | +79.50% | +112.17% | 29.49B | |
| Weighted average by Cap. | -1.07% | +2.71% | +96.19% | +133.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 263M 324M 280M 240M 451M 30.88B 458M 3.1B 1.21B 15.46B 1.21B 1.19B 51.57B | 267M 329M 285M 244M 459M 31.42B 466M 3.15B 1.23B 15.73B 1.24B 1.21B 52.46B |
| Net income | 51.57M 63.46M 55.01M 47.02M 88.47M 6.06B 89.89M 607M 237M 3.03B 238M 233M 10.11B | 39.24M 48.29M 41.86M 35.78M 67.32M 4.61B 68.4M 462M 180M 2.31B 181M 177M 7.7B |
| Net Debt | -150M -185M -160M -137M -257M -17.63B -262M -1.77B -690M -8.82B -693M -678M -29.43B | -215M -264M -229M -196M -369M -25.24B -375M -2.53B -988M -12.63B -993M -971M -42.14B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSLN Stock
- PK5 Stock
Select your edition
All financial news and data tailored to specific country editions
